Streptozotocin causes acute responses on hippocampal S100B and BDNF proteins linked to glucose metabolism alterations
Tài liệu tham khảo
Baranowska-Bosiacka, 2013, Perinatal exposure to lead induces morphological, ultrastructural and molecular alterations in the hippocampus, Toxicology, 303, 187, 10.1016/j.tox.2012.10.027
Barros, 2013, Small is fast: astrocytic glucose and lactate metabolism at cellular resolution, Front. Cell. Neurosci., 7, 27, 10.3389/fncel.2013.00027
Bathina, 2018, Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats, Lipids Health Dis., 17, 168, 10.1186/s12944-018-0809-2
Bathina, 2017, Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats, Biochem. Biophys. Res. Commun., 486, 406, 10.1016/j.bbrc.2017.03.054
Bennett, 1981, Alkylation of DNA in rat tissues following administration of streptozotocin, Cancer Res., 41, 2786
Bergami, 2008, Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes, J. Cell Biol., 183, 213, 10.1083/jcb.200806137
Biasibetti, 2017, Hippocampal changes in STZ-model of Alzheimer's disease are dependent on sex, Behav. Brain Res., 316, 205, 10.1016/j.bbr.2016.08.057
Biasibetti, 2013, Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia, Behav. Brain Res., 236, 186, 10.1016/j.bbr.2012.08.039
Biswas, 2016, Streptozotocin induced neurotoxicity involves Alzheimer's related pathological markers: a study on N2A cells, Mol. Neurobiol., 53, 2794, 10.1007/s12035-015-9144-z
Biswas, 2017, Streptozotocin alters glucose transport, connexin expression and endoplasmic reticulum functions in neurons and astrocytes, Neuroscience, 356, 151, 10.1016/j.neuroscience.2017.05.018
Brouwers, 2013, Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy, J. Biol. Chem., 288, 27200, 10.1074/jbc.M113.469486
Chen, 2013, Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies, Prog. Neurobiol., 108, 21, 10.1016/j.pneurobio.2013.06.004
de Souza, 2013, Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 43, 14, 10.1016/j.pnpbp.2012.12.001
Distler, 2012, Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights, Front. Genet., 3, 250, 10.3389/fgene.2012.00250
Donato, 2007, RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins, Curr. Mol. Med., 7, 711, 10.2174/156652407783220688
Dorofeikova, 2018, Cognitive deficit in patients with paranoid schizophrenia: its clinical and laboratory correlates, Psychiatr. Res., 262, 542, 10.1016/j.psychres.2017.09.041
Dos Santos, 2018, Early and persistent O-GlcNAc protein modification in the streptozotocin model of Alzheimer's disease, J. Alzheimer's Dis., 61, 237, 10.3233/JAD-170211
Eizirik, 1993, Genotoxic agents increase expression of growth arrest and DNA damage--inducible genes gadd 153 and gadd 45 in rat pancreatic islets, Diabetes, 42, 738, 10.2337/diab.42.5.738
Fernandes, 2014, Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis, Mol. Psychiatr., 19, 750, 10.1038/mp.2013.172
Flores-Gómez, 2019, Consequences of diabetes mellitus on neuronal connectivity in limbic regions, Synapse, 73, e22082, 10.1002/syn.22082
Frölich, 1998, Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease, J. Neural Transm., 105, 423, 10.1007/s007020050068
Galland, 2017, Hyperammonemia compromises glutamate metabolism and reduces BDNF in the rat hippocampus, Neurotoxicology, 62, 46, 10.1016/j.neuro.2017.05.006
Gonçalves, 2008, Biological and methodological features of the measurement of S100B, a putative marker of brain injury, Clin. Biochem., 41, 755, 10.1016/j.clinbiochem.2008.04.003
Gonçalves, 2018, Glycolysis-derived compounds from astrocytes that modulate synaptic communication, Front. Neurosci., 12, 1035, 10.3389/fnins.2018.01035
Gos, 2013, S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study, J. Psychiatr. Res., 47, 1694, 10.1016/j.jpsychires.2013.07.005
Hajek, 2014, Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders, Neuropsychopharmacology, 39, 2910, 10.1038/npp.2014.148
Hansen, 1989, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, J. Immunol. Methods, 119, 203, 10.1016/0022-1759(89)90397-9
Harb, 2007, Acute exposure to streptozotocin but not human proinflammatory cytokines impairs neonatal porcine islet insulin secretion in vitro but not in vivo, Xenotransplantation, 14, 580, 10.1111/j.1399-3089.2007.00427.x
Hoyer, 1994, Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism, J. Neural Transm. Suppl., 44, 259
Javed, 2012, Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type, Neuroscience, 210, 340, 10.1016/j.neuroscience.2012.02.046
Ju, 2016, Streptozotocin inhibits electrophysiological determinants of excitatory and inhibitory synaptic transmission in CA1 pyramidal neurons of rat hippocampal slices: reduction of these effects by edaravone, Cell. Physiol. Biochem., 40, 1274, 10.1159/000453181
Kalia, 2015, Biomarkers of psychiatric diseases: current status and future prospects, Metabolism, 64, S11, 10.1016/j.metabol.2014.10.026
Katakam, 2005, Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production, J. Endocrinol., 187, 237, 10.1677/joe.1.06411
Kimura, 2016, Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration, Int. J. Mol. Sci., 17, 10.3390/ijms17091584
Knezovic, 2017, Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?, J. Neural Transm., 124, 695, 10.1007/s00702-017-1727-6
Kowiański, 2018, BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity, Cell. Mol. Neurobiol., 38, 579, 10.1007/s10571-017-0510-4
Kraska, 2012, In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin, PLoS One, 7, e46196, 10.1371/journal.pone.0046196
Lannert, 1998, Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats, Behav. Neurosci., 112, 1199, 10.1037/0735-7044.112.5.1199
Leite, 2008, A simple, sensitive and widely applicable ELISA for S100B: methodological features of the measurement of this glial protein, J. Neurosci. Methods, 169, 93, 10.1016/j.jneumeth.2007.11.021
Leite, 2017, S100B secretion is mediated by Ca2+ from endoplasmic reticulum: a study using DMSO as a tool for intracellular Ca2+ mobilization, Glia, 65, E558
Marosi, 2014, BDNF mediates adaptive brain and body responses to energetic challenges, Trends Endocrinol. Metabol., 25, 89, 10.1016/j.tem.2013.10.006
Mishra, 2018, Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats, Neurochem. Int., 113, 56, 10.1016/j.neuint.2017.11.012
Nardin, 2009, S100B secretion in acute brain slices: modulation by extracellular levels of Ca(2+) and K (+), Neurochem. Res., 34, 1603, 10.1007/s11064-009-9949-0
Nardin, 2011, In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 35, 1291, 10.1016/j.pnpbp.2011.04.004
Nardin, 2016, Peripheral levels of AGEs and astrocyte alterations in the Hippocampus of STZ-diabetic rats, Neurochem. Res., 41, 2006, 10.1007/s11064-016-1912-2
Ohaeri, 2011, Metabolic syndrome in severe mental disorders, Metab. Syndrome Relat. Disord., 9, 91, 10.1089/met.2010.0053
Okusaka, 2015, Cytotoxic chemotherapy for pancreatic neuroendocrine tumors, J Hepatobiliary Pancreat Sci, 22, 628, 10.1002/jhbp.257
Pellerin, 1994, Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization, Proc. Natl. Acad. Sci. U. S. A., 91, 10625, 10.1073/pnas.91.22.10625
Peterson, 1977, A simplification of the protein assay method of Lowry et al. which is more generally applicable, Anal. Biochem., 83, 346, 10.1016/0003-2697(77)90043-4
Plaschke, 2015, In vitro streptozotocin model for modeling Alzheimer-like changes: effect on amyloid precursor protein secretases and glycogen synthase kinase-3, J. Neural Transm., 122, 551, 10.1007/s00702-014-1319-7
Rai, 2014, Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats, Pharmacol. Biochem. Behav., 117, 104, 10.1016/j.pbb.2013.11.035
Rajasekar, 2014, Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin, Neuropharmacology, 86, 337, 10.1016/j.neuropharm.2014.08.013
Rajasekar, 2016, Inhibitory effect of memantine on streptozotocin-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and neurotrophic factor decline in astrocytes, Mol. Neurobiol., 53, 6730, 10.1007/s12035-015-9576-5
Rajasekar, 2017, Intranasal insulin improves cerebral blood flow, Nrf-2 expression and BDNF in STZ (ICV)-induced memory impaired rats, Life Sci., 173, 1, 10.1016/j.lfs.2016.09.020
Regenold, 2002, Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use, J. Affect. Disord., 70, 19, 10.1016/S0165-0327(01)00456-6
Rodrigues, 2009, Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine, J. Alzheimer's Dis., 17, 193, 10.3233/JAD-2009-1034
Rosa, 2016, Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease, Neurobiol. Aging, 48, 135, 10.1016/j.neurobiolaging.2016.08.020
Rosenberger, 2008, Acute kidney injury in the diabetic rat: studies in the isolated perfused and intact kidney, Am. J. Nephrol., 28, 831, 10.1159/000137683
Salkovic-Petrisic, 2013, What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research, J. Neural Transm., 120, 233, 10.1007/s00702-012-0877-9
Saxena, 2011, ICV STZ induced impairment in memory and neuronal mitochondrial function: a protective role of nicotinic receptor, Behav. Brain Res., 224, 50, 10.1016/j.bbr.2011.04.039
Schöll, 2014, Fluorodeoxyglucose PET in neurology and psychiatry, Pet. Clin., 9, 371, 10.1016/j.cpet.2014.07.005
Serra-Millàs, 2016, Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?, World J. Psychiatr., 6, 84, 10.5498/wjp.v6.i1.84
Sharma, 2002, Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats, Life Sci., 71, 2489, 10.1016/S0024-3205(02)02083-0
Sharma, 2015, Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats, Naunyn-Schmiedeberg’s Arch. Pharmacol., 388, 337, 10.1007/s00210-014-1081-2
Souza, 2017, Activation of brain indoleamine-2,3-dioxygenase contributes to depressive-like behavior induced by an intracerebroventricular injection of streptozotocin in mice, Neurochem. Res., 42, 2982, 10.1007/s11064-017-2329-2
Stanne, 2016, Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke, Stroke, 47, 1943, 10.1161/STROKEAHA.115.012383
Steiner, 2014, Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 48, 287, 10.1016/j.pnpbp.2012.09.016
Szkudelski, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol. Res., 50, 537
Szkudelski, 2012, Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model, Exp. Biol. Med., 237, 481, 10.1258/ebm.2012.011372
Tramontina, 2008, Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 32, 1580, 10.1016/j.pnpbp.2008.06.001
Tramontina, 2007, Immunoassay for glial fibrillary acidic protein: antigen recognition is affected by its phosphorylation state, J. Neurosci. Methods, 162, 282, 10.1016/j.jneumeth.2007.01.001
Vicente, 2007, S100B levels in the cerebrospinal fluid of rats are sex and anaesthetic dependent, Clin. Exp. Pharmacol. Physiol., 34, 1126
Wartchow, 2016, Insulin stimulates S100B secretion and these proteins antagonistically modulate brain glucose metabolism, Neurochem. Res., 41, 1420, 10.1007/s11064-016-1851-y